The Effect of Cognitive Training in Patients with Mild Cognitive Impairment and Early Alzheimer's Disease: A Preliminary Study

被引:27
|
作者
Hwang, Hye Ran [1 ]
Choi, Seong Hye [1 ]
Yoon, Dae Hyun [2 ]
Yoon, Byung-Nam [1 ,3 ]
Suh, Young Ju [4 ]
Lee, DaeHyung [5 ]
Han, Im-Tae [1 ]
Hong, Chang-Gi [1 ]
机构
[1] Inha Univ, Sch Med, Dept Neurol, Inchon 400711, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr,Dept Psychiat, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea
[4] Inha Univ, Sch Med, Clin Res Inst, Inchon 400711, South Korea
[5] Inha Univ Hosp, Clin Trial Ctr, Inchon 400711, South Korea
来源
JOURNAL OF CLINICAL NEUROLOGY | 2012年 / 8卷 / 03期
关键词
Alzheimer's disease; cognitive therapy; memory; mild cognitive impairment; training; OLDER-ADULTS; MEMORY; REHABILITATION; INTERVENTION; INDIVIDUALS; BENEFITS; MCI;
D O I
10.3988/jcn.2012.8.3.190
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose The objective of this study was to determine the benefits of cognitive training in patients with amnestic mild cognitive impairment (aMCI) and those with early Alzheimer's disease (AD). Methods Eleven patients with aMCI and nine with early AD (stage 4 on the Global Deterioration Scale) participated in this study. Six participants with aMCI and six with AD were allocated to the cognitive training group, while five participants with aMCI and three with AD were allocated to a wait-list control group. Multicomponent cognitive training was administered in 18 weekly, individual sessions. Outcome measures were undertaken at baseline, and at 2 weeks and 3 months of follow-up. Results In the trained MCI group, there were significant improvements in the delayed-recall scores on the Seoul Verbal Learning Test at both the 2-week and 3-month follow-ups compared with baseline (baseline, 1.6 +/- 1.5; 2 weeks, 4.4 +/- 1.5, p=0.04; 3 months, 4.6 +/- 2.3, p=0.04). The phonemic fluency scores (1.0 +/- 0.8 vs. 5.0 +/- 1.8, p=0.07) and Korean Mini-Mental State Examination scores (18.8 +/- 0.5 vs. 23.8 +/- 2.2, p=0.07) also showed a tendency toward improvement at the 2-week follow-up compared to baseline in the trained AD group. Conclusions This study provides evidence of the effectiveness of cognitive training in aMCI and early AD. The efficacy of cognitive training programs remains to be verified in studies with larger samples and a randomized design. J Clin Neurol 2012;8:190-197
引用
收藏
页码:190 / 197
页数:8
相关论文
共 50 条
  • [31] Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment
    Levinoff, EJ
    Phillips, NA
    Verret, L
    Babins, L
    Kelner, N
    Akerib, V
    Chertkow, H
    [J]. NEUROPSYCHOLOGY, 2006, 20 (01) : 123 - 132
  • [32] Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study
    Watson, GS
    Cholerton, BA
    Reger, MA
    Baker, LD
    Plymate, SR
    Asthana, S
    Fishel, MA
    Kulstad, JJ
    Green, PS
    Cook, DG
    Kahn, SE
    Keeling, ML
    Craft, S
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (11): : 950 - 958
  • [33] Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease
    Guidi, I
    Galimberti, D
    Lonati, S
    Novembrino, C
    Bamonti, F
    Tiriticco, M
    Fenoglio, C
    Venturelli, E
    Baron, P
    Bresolin, N
    Scarpini, E
    [J]. NEUROBIOLOGY OF AGING, 2006, 27 (02) : 262 - 269
  • [34] Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
    Kesler, Anat
    Vakhapova, Veronika
    Korczyn, Amos D.
    Naftaliev, Elvira
    Neudorfer, Meira
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (07) : 523 - 526
  • [35] Brain metabolism in patients with mild cognitive impairment and Alzheimer's disease
    Samaranch, L
    Arbizu, J
    Martinez-Lage, P
    Lamet, I
    Masdeu, J
    Martinez-Lage, JM
    Marti-Climent, JM
    Serra, P
    Garcia, D
    Ramos, M
    Bescos, E
    Gomez-Isla, T
    [J]. NEUROLOGY, 2005, 64 (06) : A93 - A94
  • [36] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166
  • [37] Mild cognitive impairment: Aging to Alzheimer's disease
    Heilbronner, RL
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (05) : 718 - 722
  • [38] FMRI in mild cognitive impairment and Alzheimer's disease
    Rombouts, S
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S49 - S49
  • [39] Galantamine for Alzheimer's disease and mild cognitive impairment
    Cusi, Cristina
    Cantisani, Teresa Anna
    Celani, Maria Grazia
    Incorvaia, Barbara
    Righetti, Enrico
    Candelise, Livia
    [J]. NEUROEPIDEMIOLOGY, 2007, 28 (02) : 116 - 117
  • [40] Dysgraphia in Alzheimer's disease with mild cognitive impairment
    Kavrie, S
    Neils-Strunjas, J
    [J]. JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 2002, 10 (01) : 73 - 85